UK Innovation & Science Seed Fund

The UK Innovation & Science Seed Fund, established in 2002 and based in Birmingham, is a venture capital firm supported by the Department for Business, Energy and Industrial Strategy and nine publicly funded research bodies, including STFC, BBSRC, NERC, and Dstl. Managed independently by Midven, the Fund focuses on nurturing companies that emerge from cutting-edge scientific research conducted in laboratories and technology campuses across the UK. It invests in a range of sectors, including healthcare, life sciences, information technology, advanced manufacturing, software as a service, and agricultural technology. The Fund holds stakes in some of the UK's most innovative companies, contributing to advancements in areas such as novel antibiotics, Alzheimer’s disease research, sustainable chemicals, and airport security technologies.

Alexander Leigh

Investment Director

Mark White

Investment Director Fusion and Investment Committee Member

Past deals in United Kingdom

Adamo Foods

Seed Round in 2024
Adamo Foods is a UK-based food technology company specializing in the development of plant-based whole-cut meats. Utilizing proprietary fermentation technology alongside mycelium, the company produces sustainable steak and other meat alternatives. Adamo Foods aims to provide functional meat proteins through precision fermentation, offering consumers an efficient, sustainable, and ethical food option that does not compromise on taste or experience.

Wave Photonics

Seed Round in 2024
Wave Photonics is a company based in Cambridge, UK, focused on enhancing the design and integration of integrated photonics products. It develops a platform that utilizes computational techniques to optimize product designs and streamline the supply chain. This platform offers a software tool that predicts the performance and variability of components based on specific fabrication processes, along with an optimizer to create a library of foundry-specific components. By facilitating the development and mass production of integrated photonics technologies, Wave Photonics aims to improve efficiency and reduce redundancy for businesses in the sector.

MIRICO

Venture Round in 2024
MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Vector Photonics

Seed Round in 2024
Vector Photonics, based in Glasgow, Scotland, is a spin-out company from the University of Glasgow. It specializes in developing semiconductor laser technology for data communications and additive manufacturing, including metal and plastic printing. The company's innovation lies in photonic crystal surface-emitting lasers, which are low-cost and emit light from the top surface, facilitating easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies. This enables various industries to adopt their semiconductor laser technology in daily operations.

Oxford Space Systems

Venture Round in 2024
Oxford Space Systems Limited is a Harwell, United Kingdom-based company that specializes in the development and manufacturing of deployable hardware structures for space environments. Founded in 2013, the company has gained recognition for its innovative designs, including deployable antennas, panels, hinge systems, and composite linear boom systems. Utilizing advanced techniques such as origami and proprietary materials, Oxford Space Systems creates solutions that are lighter, more efficient, and cost-effective compared to traditional alternatives, catering to the global satellite industry. The company's AstroTube Boom set a record for the fastest product development from concept to successful deployment in under 30 months. With a team of 18 professionals, combining diverse backgrounds and over a century of collective experience in the space sector, Oxford Space Systems has engaged in various collaborative projects with leading European satellite manufacturers and has secured commercial contracts across Asia and the US. The company operates from a state-of-the-art facility within the Harwell Space Cluster, equipped to meet the security requirements necessary for defense and security contracts.

Oxford Space Systems

Grant in 2024
Oxford Space Systems Limited is a Harwell, United Kingdom-based company that specializes in the development and manufacturing of deployable hardware structures for space environments. Founded in 2013, the company has gained recognition for its innovative designs, including deployable antennas, panels, hinge systems, and composite linear boom systems. Utilizing advanced techniques such as origami and proprietary materials, Oxford Space Systems creates solutions that are lighter, more efficient, and cost-effective compared to traditional alternatives, catering to the global satellite industry. The company's AstroTube Boom set a record for the fastest product development from concept to successful deployment in under 30 months. With a team of 18 professionals, combining diverse backgrounds and over a century of collective experience in the space sector, Oxford Space Systems has engaged in various collaborative projects with leading European satellite manufacturers and has secured commercial contracts across Asia and the US. The company operates from a state-of-the-art facility within the Harwell Space Cluster, equipped to meet the security requirements necessary for defense and security contracts.

HydRegen

Seed Round in 2023
HydRegen is a biotechnology company founded in 2020 and headquartered in Oxford, United Kingdom. The company specializes in providing sustainable solutions for chemical manufacturing through the development of bio-based manufacturing technologies. Utilizing innovative biocatalysis techniques, HydRegen aims to enhance agility, speed, and predictability during the early stages of industrial research and development. This approach enables the chemicals and pharmaceutical sectors to validate their processes while meeting essential requirements for cost, productivity, and reproducibility at scale.

Vitarka Therapeutics

Seed Round in 2023
Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Productive Machines

Seed Round in 2023
Productive Machines is a company that specializes in software optimization services for the machining industry, focusing on enhancing productivity and sustainability for manufacturers. By leveraging a digital twin of the machining process, which simulates the physics, mechanics, dynamics, distortion, and vibration involved in metal cutting, Productive Machines enables manufacturers to test millions of parameters in a virtual environment. This innovative approach allows for improved Computer-Aided Manufacturing (CAM) and Gcode, effectively eliminating chatter vibrations, reducing cycle times, minimizing tooling costs, and enhancing surface finish and dimensional accuracy. As a spin-out from the UK Advanced Manufacturing Research Centre, Productive Machines aims to streamline machining processes, empowering companies to achieve higher quality parts more efficiently and cost-effectively.

Vector Photonics

Seed Round in 2023
Vector Photonics, based in Glasgow, Scotland, is a spin-out company from the University of Glasgow. It specializes in developing semiconductor laser technology for data communications and additive manufacturing, including metal and plastic printing. The company's innovation lies in photonic crystal surface-emitting lasers, which are low-cost and emit light from the top surface, facilitating easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies. This enables various industries to adopt their semiconductor laser technology in daily operations.

MIRICO

Funding Round in 2022
MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Vector Photonics

Seed Round in 2021
Vector Photonics, based in Glasgow, Scotland, is a spin-out company from the University of Glasgow. It specializes in developing semiconductor laser technology for data communications and additive manufacturing, including metal and plastic printing. The company's innovation lies in photonic crystal surface-emitting lasers, which are low-cost and emit light from the top surface, facilitating easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies. This enables various industries to adopt their semiconductor laser technology in daily operations.

Linear Diagnostics

Venture Round in 2021
Linear Diagnostics Limited is a diagnostic technology company based in Birmingham, United Kingdom, founded in 2011. The company specializes in developing a novel diagnostic platform that utilizes linear dichroism (LD) to perform a wide range of molecular diagnostics tests. This technology allows for the rapid detection of multiple targets from a single sample, providing significant advantages over conventional methods. Linear Diagnostics focuses on various applications, including the detection of antibiotic resistance in infections and identifying bacteria responsible for food crop spoilage. Additionally, the company offers a handheld reader designed for measuring LD signals, enhancing the accessibility and efficiency of its diagnostic solutions. By addressing limitations associated with traditional detection techniques, Linear Diagnostics aims to improve healthcare outcomes and reduce costs.

Atelerix

Venture Round in 2020
Atelerix Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2006. It specializes in the storage and transportation of cells and tissues at room temperature, utilizing a patented technology that encapsulates biological products in a natural hydrogel. This innovative approach allows for the safe shipment and storage of viable cells, including suspended cells, planted cells, and stem cells, without the need for cryopreservation or harmful supplements. By protecting cells from biochemical and physical damage, Atelerix enables immediate use of cells and assays upon arrival, enhancing reliability in drug discovery and cell therapy applications. The company's technology contributes to more predictable and effective outcomes in medical and research settings.

Atelerix

Venture Round in 2019
Atelerix Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2006. It specializes in the storage and transportation of cells and tissues at room temperature, utilizing a patented technology that encapsulates biological products in a natural hydrogel. This innovative approach allows for the safe shipment and storage of viable cells, including suspended cells, planted cells, and stem cells, without the need for cryopreservation or harmful supplements. By protecting cells from biochemical and physical damage, Atelerix enables immediate use of cells and assays upon arrival, enhancing reliability in drug discovery and cell therapy applications. The company's technology contributes to more predictable and effective outcomes in medical and research settings.

MIRICO

Venture Round in 2018
MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Atelerix

Seed Round in 2018
Atelerix Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2006. It specializes in the storage and transportation of cells and tissues at room temperature, utilizing a patented technology that encapsulates biological products in a natural hydrogel. This innovative approach allows for the safe shipment and storage of viable cells, including suspended cells, planted cells, and stem cells, without the need for cryopreservation or harmful supplements. By protecting cells from biochemical and physical damage, Atelerix enables immediate use of cells and assays upon arrival, enhancing reliability in drug discovery and cell therapy applications. The company's technology contributes to more predictable and effective outcomes in medical and research settings.

SFH Oxford

Seed Round in 2018
SFH Oxford Ltd. is a UK-based company specializing in the development and marketing of innovative healthcare products aimed at enhancing the management of venous leg ulcers. Founded in 2011 and located in Didcot, the company has created Graducheck, a sensor-based technology that improves the application of compression bandages, thereby increasing healing rates and promoting patient compliance. SFH Oxford also offers anatomic focus technology graduated compression socks, which provide essential graduated compression, and K-gel wound dressings. The company is actively engaged in clinical and field trials for several of its products, which are showing promising results in real-world applications. With a leadership team experienced in medical device technology, wound care, and business development, SFH Oxford is focused on delivering optimized care for patients and healthcare professionals involved in ulcer management.

Synthace

Series A in 2017
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Puraffinity

Grant in 2017
Puraffinity Ltd., established in London in 2015, specialises in innovative water treatment solutions. The company designs and develops precision materials, notably a sustainable adsorbent capable of removing challenging pollutants like pesticides, pharmaceuticals, and PFAS from contaminated water and wastewater. Utilising advanced supramolecular chemistry methods, Puraffinity's technology binds target chemicals selectively, enabling clients to meet stringent regulations and protect local ecosystems sustainably.

Cytox

Series B in 2017
Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.

Linear Diagnostics

Seed Round in 2017
Linear Diagnostics Limited is a diagnostic technology company based in Birmingham, United Kingdom, founded in 2011. The company specializes in developing a novel diagnostic platform that utilizes linear dichroism (LD) to perform a wide range of molecular diagnostics tests. This technology allows for the rapid detection of multiple targets from a single sample, providing significant advantages over conventional methods. Linear Diagnostics focuses on various applications, including the detection of antibiotic resistance in infections and identifying bacteria responsible for food crop spoilage. Additionally, the company offers a handheld reader designed for measuring LD signals, enhancing the accessibility and efficiency of its diagnostic solutions. By addressing limitations associated with traditional detection techniques, Linear Diagnostics aims to improve healthcare outcomes and reduce costs.

Nemesis Bioscience

Seed Round in 2017
Nemesis Bioscience Ltd., established in 2014 and headquartered in Cambridge, UK, specializes in developing and commercializing innovative therapeutic agents. The company's core focus is to restore the effectiveness of existing antibiotics against currently resistant microbial pathogens. Nemesis Bioscience achieves this through its symbiotics, which directly kill pathogenic microorganisms and/or sensitize them to currently available antibiotics. The company's solutions are employed to treat infections and prevent patients from acquiring potentially life-threatening resistant pathogens. Nemesis Bioscience has been recognized for its work, having received the King's College, Cambridge Entrepreneurship Award in 2014, and has filed international patent applications for its inventions.

The Electrospinning Company

Angel Round in 2017
The Electrospinning Company Ltd. specializes in designing, developing, and manufacturing innovative biomaterials for regenerative medical applications and 3D cell culture products. Founded in 2008 and located in Didcot, United Kingdom, the company offers a range of products including aligned fiber scaffolds, plates with removable scaffold discs, and tissue culture plates. These biomaterials are synthetic polymer-based and are designed to mimic the human body's natural extracellular matrix, facilitating post-surgery recovery and supporting tissue-engineering efforts. In addition to its product offerings, The Electrospinning Company provides a variety of services, such as scaffold design, development of sterilization protocols, packaging solutions, and regulatory support for clinical trials. The company also collaborates with academic researchers to develop novel nanofibre solutions for scientific applications, making it a key player in the fields of tissue engineering, regenerative medicine, and drug discovery. Products are available for purchase online.

Keit

Venture Round in 2016
Keit Ltd. is a company specializing in the design and manufacture of advanced spectrometers and related instruments, catering to a wide range of applications from ultraviolet to far infrared rays. Incorporated in 2012 and headquartered in Didcot, United Kingdom, Keit is known for its innovative microFTS® design, a Fourier Transform Infrared (FTIR) spectrometer that is notably smaller, lighter, and more rugged than existing systems. Originally developed for space applications, the microFTS® is capable of operating in extreme environments and sets a new standard for real-time liquid-state analyses across various industries, including Pharmaceutical, Chemical, Oil & Gas, and Food & Beverage. Keit's products are also utilized for measuring signal levels, near line vibrations, and analyzing gas or liquid-borne species.

MIRICO

Seed Round in 2016
MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Quethera

Seed Round in 2015
Quethera Limited is a biotechnology company based in Canterbury, United Kingdom, focused on developing gene therapy treatments for glaucoma and other ophthalmic diseases. Established in 2013, the company aims to address progressive visual loss associated with these conditions, particularly in patients experiencing accelerated deterioration of their visual fields. Quethera collaborates with leading experts in the field of glaucoma to design and conduct clinical trials that assess the efficacy and safety of its innovative therapies. With a strong foundation in gene therapeutic design and development, Quethera is advancing its pipeline from preclinical testing into clinical development, striving to provide effective treatment solutions for common blinding eye diseases. As of 2018, Quethera operates as a subsidiary of Astellas Pharma Inc.

Oxford Space Systems

Venture Round in 2015
Oxford Space Systems Limited is a Harwell, United Kingdom-based company that specializes in the development and manufacturing of deployable hardware structures for space environments. Founded in 2013, the company has gained recognition for its innovative designs, including deployable antennas, panels, hinge systems, and composite linear boom systems. Utilizing advanced techniques such as origami and proprietary materials, Oxford Space Systems creates solutions that are lighter, more efficient, and cost-effective compared to traditional alternatives, catering to the global satellite industry. The company's AstroTube Boom set a record for the fastest product development from concept to successful deployment in under 30 months. With a team of 18 professionals, combining diverse backgrounds and over a century of collective experience in the space sector, Oxford Space Systems has engaged in various collaborative projects with leading European satellite manufacturers and has secured commercial contracts across Asia and the US. The company operates from a state-of-the-art facility within the Harwell Space Cluster, equipped to meet the security requirements necessary for defense and security contracts.

Synthace

Venture Round in 2015
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Synthace

Series A in 2014
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Tokamak Energy

Venture Round in 2014
Tokamak Energy Ltd is a private company based in Abingdon, United Kingdom, focused on the development of fusion power technology. Founded in 2009, the company specializes in creating compact and cost-effective fusion power devices, particularly through the use of spherical tokamaks. These innovative reactors are designed to achieve higher plasma pressure with reduced magnetic field requirements compared to traditional tokamaks. Tokamak Energy utilizes high-temperature superconducting magnets to enhance plasma control within its devices, thereby improving efficiency. The company's commitment to rapid innovation leverages advanced materials and technology, building on decades of scientific research. By aiming to develop commercial fusion power solutions, Tokamak Energy contributes to the pursuit of affordable and sustainable energy, addressing global energy security while minimizing environmental impact.

SFH Oxford

Seed Round in 2013
SFH Oxford Ltd. is a UK-based company specializing in the development and marketing of innovative healthcare products aimed at enhancing the management of venous leg ulcers. Founded in 2011 and located in Didcot, the company has created Graducheck, a sensor-based technology that improves the application of compression bandages, thereby increasing healing rates and promoting patient compliance. SFH Oxford also offers anatomic focus technology graduated compression socks, which provide essential graduated compression, and K-gel wound dressings. The company is actively engaged in clinical and field trials for several of its products, which are showing promising results in real-world applications. With a leadership team experienced in medical device technology, wound care, and business development, SFH Oxford is focused on delivering optimized care for patients and healthcare professionals involved in ulcer management.

Tokamak Solutions

Seed Round in 2011
Tokamak Solutions UK Ltd. engages in providing technology for fusion neutron source to transmute nuclear waste. The company was founded in 2009 and is based in Abingdon, United Kingdom.

Microvisk Technologies

Series C in 2011
Microvisk Technologies is a UK-based company founded in 2004, specializing in the development of advanced medical devices. The company's flagship product, CoagMax, is a point-of-care monitor designed for home patient testing of INR blood levels. Utilizing innovative micro electro mechanical sensors, CoagMax allows patients to self-test in a convenient, safe, and less painful manner. The device incorporates a novel sensor chip embedded in a disposable smart strip, ensuring accurate and efficient coagulation monitoring. Through its technology, Microvisk aims to enhance patient autonomy and improve health outcomes in the management of coagulation disorders.

Microvisk Technologies

Venture Round in 2010
Microvisk Technologies is a UK-based company founded in 2004, specializing in the development of advanced medical devices. The company's flagship product, CoagMax, is a point-of-care monitor designed for home patient testing of INR blood levels. Utilizing innovative micro electro mechanical sensors, CoagMax allows patients to self-test in a convenient, safe, and less painful manner. The device incorporates a novel sensor chip embedded in a disposable smart strip, ensuring accurate and efficient coagulation monitoring. Through its technology, Microvisk aims to enhance patient autonomy and improve health outcomes in the management of coagulation disorders.

P2i

Venture Round in 2010
P2i Limited is a leading provider of liquid repellent nano-coating technology, specializing in pulsed plasma deposition processes that create hydrophobic coatings for various materials. Founded in 2003 and headquartered in Abingdon, United Kingdom, P2i offers innovative solutions that enhance the performance of products across multiple industries, including electronics, lifestyle, life sciences, filtration, energy, and military applications. The company's cutting-edge coatings enable surfaces to repel liquids, allowing them to bead up and roll off without altering the original appearance or texture of the materials. P2i serves a global market, with processing facilities in the United States, an office in Singapore, and applications centers in China, helping original equipment manufacturers (OEMs) protect their products from water damage and other liquid exposure.

Microvisk Technologies

Venture Round in 2010
Microvisk Technologies is a UK-based company founded in 2004, specializing in the development of advanced medical devices. The company's flagship product, CoagMax, is a point-of-care monitor designed for home patient testing of INR blood levels. Utilizing innovative micro electro mechanical sensors, CoagMax allows patients to self-test in a convenient, safe, and less painful manner. The device incorporates a novel sensor chip embedded in a disposable smart strip, ensuring accurate and efficient coagulation monitoring. Through its technology, Microvisk aims to enhance patient autonomy and improve health outcomes in the management of coagulation disorders.

Orbital Optics

Seed Round in 2006
Orbital Optics specializes in the manufacture and sale of high-resolution optical cameras designed for space missions, catering to both the United Kingdom and international markets. The company focuses on producing compact and affordable space cameras that deliver high-quality images. In addition to its camera manufacturing, Orbital Optics offers consultancy services related to imaging systems and optical payloads, along with access to supporting ground station facilities.

Oxsensis

Venture Round in 2005
Oxsensis Ltd. is a manufacturer of non-electrical sensor systems that specialize in optical sensors for measuring pressure, temperature, and vibration in extreme environments. Founded in 2003 and headquartered in Didcot, United Kingdom, the company also operates additional offices in the United States, Russia, China, and Japan. Its product offerings include advanced optical instrumentation such as the Wave-Phire Dynamic Pressure Transducer, which is designed for harsh conditions like gas turbines, and the i-Phire 4 Channel Optical Interrogator Unit, which converts optical signals into voltage signals for dynamic pressure measurements. Oxsensis serves a diverse range of industries including aerospace, power generation, oil and gas, and space, focusing on applications that require high sensitivity and immunity to electromagnetic interference. The company's innovative solutions contribute to precision controls and health monitoring in high-temperature and safety-critical environments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.